The bulk of the L Capital Asia team that merged with Catterton in 2016 to form L Catterton, a global consumer-focused private equity firm, is spinning out to raise a $750 million Asia growth fund.
The group includes 12 of L Catterton’s 14 Asia-based partners, led by Ravi Thakran (pictured), the managing partner and chairman for the region. They have agreed a management buyout of the first two...
China-based data storage software services provider XSKY has raised a RMB320 million ($45 million) Series D led by China's State Owned Capital Venture Capital Fund.
CF PharmTech, a Chinese medical devices maker focused on innovative respiratory products, has raised a $50 million Series F round with support from CICC Capital.
Chinese insulin manufacturer Gan & Lee Pharmaceuticals, which counts Qiming Venture Partners and Goldman Sachs among its investors, raised RMB2.5 billion ($354 million) through an A-share IPO.
KKR has agreed to buy a 54% stake in Indian drug maker J.B. Chemicals & Pharmaceuticals for INR31.1 billion ($416 million) and made an open offer for an additional 26% of the company.